RxDoctor Payments Data

John Carucci, MD

MOHS-Micrographic Surgery · New York, NYNPI 1265520530

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,055 of the $6,188 with a category attached, or 97.8%. Genentech USA, Inc. accounts for 97.8% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2020 at $6,055 and has fallen 98.9% since, to $69 in 2024.

$6,188in general payments, 2019–2025

Across 4 payments — averaging $1547.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$6K
  • Incyte Corporation$133
$612,126in research payments, 2019–2025

Across 42 payments — averaging $14,574 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$564K
  • Incyte Corporation$48K

What the payments were for

  • Consulting fees$6,05598%
  • Food & beverage$1332%

General payments by program year

19
20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech USA, Inc.1$6,055
Incyte Corporation3$133

How this compares

$6,188 in reported general payments places this provider in the 75th percentile of 75 mohs-micrographic surgery providers in New York.

See all mohs-micrographic surgery providers in New York

Medicare billing

Part B allowed, 2024
$978,351
Medicare patients
582
Services billed
3,787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin437$2,200
Doxycycline Hyclate112$663
Mupirocin93$617
Gentamicin Sulfate11$381
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen32$121
Acetaminophen-CodeineAcetaminophen With Codeine15$35

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →